- Home
- RCKY vs BIOA Comparison
RCKY vs BIOA Comparison
Compare RCKY & BIOA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RCKY
- BIOA
- Stock Information
- Founded
- RCKY 1932
- BIOA 2015
- Country
- RCKY United States
- BIOA United States
- Employees
- RCKY N/A
- BIOA N/A
- Industry
- RCKY Shoe Manufacturing
- BIOA Biotechnology: Pharmaceutical Preparations
- Sector
- RCKY Consumer Discretionary
- BIOA Health Care
- Exchange
- RCKY Nasdaq
- BIOA Nasdaq
- Market Cap
- RCKY 205.3M
- BIOA 175.7M
- IPO Year
- RCKY 1993
- BIOA 2024
- Fundamental
- Price
- RCKY $29.29
- BIOA $7.50
- Analyst Decision
- RCKY Buy
- BIOA Hold
- Analyst Count
- RCKY 1
- BIOA 4
- Target Price
- RCKY $40.00
- BIOA $9.00
- AVG Volume (30 Days)
- RCKY 78.6K
- BIOA 664.8K
- Earning Date
- RCKY 10-28-2025
- BIOA 11-06-2025
- Dividend Yield
- RCKY 2.12%
- BIOA N/A
- EPS Growth
- RCKY 53.66
- BIOA N/A
- EPS
- RCKY 2.74
- BIOA N/A
- Revenue
- RCKY $470,314,000.00
- BIOA $3,863,000.00
- Revenue This Year
- RCKY $7.09
- BIOA N/A
- Revenue Next Year
- RCKY $4.27
- BIOA N/A
- P/E Ratio
- RCKY $10.69
- BIOA N/A
- Revenue Growth
- RCKY 4.13
- BIOA N/A
- 52 Week Low
- RCKY $11.93
- BIOA $2.88
- 52 Week High
- RCKY $31.38
- BIOA $23.72
- Technical
- Relative Strength Index (RSI)
- RCKY 54.50
- BIOA 65.90
- Support Level
- RCKY $27.96
- BIOA $7.09
- Resistance Level
- RCKY $29.36
- BIOA $8.15
- Average True Range (ATR)
- RCKY 1.34
- BIOA 0.46
- MACD
- RCKY 0.04
- BIOA 0.05
- Stochastic Oscillator
- RCKY 54.75
- BIOA 68.93
About RCKY Rocky Brands Inc.
Rocky Brands Inc acts as a designer, manufacturer, and marketer of premium-quality footwear and apparel. The company's family of brands includes Rocky, Georgia Boot, Durango, Lehigh, Creative Recreation, and the licensed brand Michelin footwear. The company operates its business through three business segments: Wholesale, Retail and Contract Manufacturing. It generates the majority of the revenue from the Wholesale segment.
About BIOA BioAge Labs Inc. Common Stock
Bioage Labs Inc is a clinical-stage biopharmaceutical company developing therapeutic product candidates for metabolic diseases, such as obesity, by targeting the biology of human aging. Its focus is metabolic disease, one of the greatest healthcare challenges. The pipeline Products of the company are NLRP3 inhibitors, APJ against, and others.